864448-41-9

Basic information

• Product Name: 7-Boc-3-oxa-7,9-diazabicyclo[3.3.1]nonane
• Synonyms: 7-Boc-3-oxa-7,9-diazabicyclo[3.3.1]nonane;3-Oxa-7,9-diazabicyclo[3.3.1]nonane-7-carboxylic acid tert-butyl ester;tert-Butyl 3-oxa-7,9-diazabicyclo[3.3.1]nonane-7-carboxylate
• CAS NO: 864448-41-9
• Molecular Formula: C₁₁H₂₀N₂O₃
• Molecular Weight: 228.2881
• Mol File: 864448-41-9.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 324.9±42.0 °C(Predicted)
• Appearance: /
• Density: 1.108±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 7.70±0.20(Predicted)
• CAS DataBase Reference: 7-Boc-3-oxa-7,9-diazabicyclo[3.3.1]nonane(CAS DataBase Reference)
• NIST Chemistry Reference: 7-Boc-3-oxa-7,9-diazabicyclo[3.3.1]nonane(864448-41-9)
• EPA Substance Registry System: 7-Boc-3-oxa-7,9-diazabicyclo[3.3.1]nonane(864448-41-9)

Safety Data

• Hazardous Substances Data: 864448-41-9(Hazardous Substances Data)

Usage

Uses

tert-Butyl 3-Oxa-7,9-diazabicyclo[3.3.1]nonane-7-carboxylate is a building block for the preparation of other biologically active small molecules

Upstream product

• 335620-96-7 9-benzyl-3-(phenylsulfonyl)-7-oxa-3,9-diaza-bicyclo[3.3.1]nonane 
• 864448-39-5 9-benzyl-3-oxa-7,9-diazabicyclo[3.3.1]nonane 
• 864448-26-0 (meso)-4-benzenesulfonyl-1-benzylpiperazine-2,6-dicarboxylic acid diethyl ester 
• 864448-27-1 cis-(1-benzyl-4-(phenylsulfonyl)piperazine-2,6-diyl)dimethanol 
• 864448-25-9 (S)-ethyl 2-bromo-3-(N-((R)-2-bromo-3-ethoxy-3-oxopropyl)phenyl-sulfonamido)propanoate 
• 864448-40-8 9-benzyl-3-oxa-7,9-diazabicyclo[3.3.1]nonane-7-carboxylic acid tert-butyl ester 

Downstream Products

• 868408-10-0 2-chloro-1-[9-(4-fluorobenzyl)-3-oxa-7,9-diazabicyclo[3.3.1]non-7-yl]-ethanone 
• 868408-12-2 (E)-(5-chloro-2-{3-[9-(4-fluorobenzyl)-3-oxa-7,9-diazabicyclo[3.3.1]non-7-yl]-3-oxopropenyl}-phenyl)-carbamic acid tert-butyl ester 
• 864448-44-2 9-(4-fluorobenzyl)-3-oxa-7,9-diazabicyclo[3.3.1]nonane-7-carboxylic acid tert-butyl ester 

Relevant articles and documents

COMPOUNDS AS CCRI ANTAGONISTS

A compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, wherein the symbols have meaning as defined, which are antagonists of CCR-1 and which find use pharmaceutically for treatment of diseases and conditions in which CCR-1 is implicated, e.g. inflammatory diseases.